MONTANO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.723
EU - Europa 372
AS - Asia 139
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.240
Nazione #
US - Stati Uniti d'America 4.723
DE - Germania 74
UA - Ucraina 71
SE - Svezia 64
CN - Cina 63
SG - Singapore 49
IE - Irlanda 36
IT - Italia 30
GB - Regno Unito 27
FR - Francia 18
FI - Finlandia 16
KR - Corea 14
RU - Federazione Russa 12
BE - Belgio 10
KG - Kirghizistan 8
PL - Polonia 8
VN - Vietnam 5
CL - Cile 2
RO - Romania 2
AU - Australia 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
MA - Marocco 1
MD - Moldavia 1
NL - Olanda 1
SC - Seychelles 1
Totale 5.240
Città #
Woodbridge 1.529
Wilmington 1.282
Houston 962
Fairfield 151
Ann Arbor 146
Chandler 103
Ashburn 92
Jacksonville 69
Cambridge 62
Seattle 62
Dearborn 40
Dublin 36
Singapore 35
Medford 31
Beijing 20
Zhengzhou 17
Lawrence 14
Brussels 10
Mülheim 9
Rome 8
San Mateo 8
Shanghai 8
Kraków 7
Los Angeles 7
Boardman 6
Hefei 5
Menlo Park 5
Milan 5
Moscow 5
San Diego 5
University Park 5
Dong Ket 4
New York 4
Auburn Hills 3
Falls Church 3
Guangzhou 3
Phoenix 3
Santa Clara 3
Verona 3
Hebei 2
Helsinki 2
Kilburn 2
London 2
Mountain View 2
Nanjing 2
Norwalk 2
Palo Alto 2
Washington 2
Baotou 1
Bologna 1
Cave 1
Chengdu 1
Chisinau 1
Crown City 1
Englewood 1
Fuzhou 1
Hanoi 1
Indiana 1
Kunming 1
Kunshan 1
Laurel 1
Melbourne 1
Nanning 1
Nuremberg 1
Pitesti 1
Redmond 1
Redwood City 1
Saint Paul 1
Saint Petersburg 1
San Francisco 1
Southwark 1
Stockholm 1
Tappahannock 1
Warsaw 1
Totale 4.814
Nome #
Therapeutic DNA Vaccination of Vertically HIV-Infected Children: Report of the First Pediatric Randomised Trial (PEDVAC) 457
Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission 444
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 420
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens 414
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 383
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 374
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 368
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 362
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group 355
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 350
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 348
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children 341
Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. 319
Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy 316
Totale 5.251
Categoria #
all - tutte 9.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.235 0 135 99 126 122 148 138 110 97 107 69 84
2020/2021695 88 81 76 100 53 66 82 62 19 16 30 22
2021/2022191 7 19 20 12 12 19 10 4 15 19 8 46
2022/2023237 21 15 11 44 15 56 18 18 20 0 12 7
2023/202459 12 2 6 1 5 10 2 2 0 6 0 13
2024/202553 14 39 0 0 0 0 0 0 0 0 0 0
Totale 5.251